article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

Prior to joining Convoy in 2018, Kreiner was CEO of Cal Net Technology Group and a managing partner at Olympic Valley Capital. Portland-based Sparrow Pharmaceuticals appointed Frank Czerwiec as chief medical officer and Jamie MacPherson as VP of regulatory affairs and quality. Seattle-based Marchex appointed Ryan Polley as COO.

CTO Hire 137
article thumbnail

NLP helps Eli Lilly work at a global scale

CIO Business Intelligence

With more than 30,000 employees spread across more than 60 affiliate locations and 14 manufacturing sites around the world, pharmaceutical company Eli Lilly operates at a truly global scale. The Lilly Translate API and UI are delivered via a serverless tech stack built on Node.js, Python,NET, and Docker.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Founder and CEO Adam Simpson formerly led another IPD spinout, PvP Biologics, which sold to the pharmaceutical company Takeda. Net losses were $5.3 The company’s virus-like particle technology was invented at the Institute for Protein Design by Neil King, a scientific co-founder of Icosavax along with IPD head David Baker.

article thumbnail

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

GeekWire

The Seattle-based company posted a net loss of $31.4 Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. million, or 25 cents a share, vs. a loss of $18.4

article thumbnail

Seagen vets land $4.4M for Univ. of Washington spinout using fresh approach for cancer vaccines

GeekWire

The net effect is, ideally, an immune onslaught against the tumor. Wahl has served as a consultant to biopharma companies for the last seven years and was previously vice president of discovery at Ambrx and held research leadership roles at AbbVie, Biogen Idec, Trubion Pharmaceuticals, and Bristol Myers Squibb.

article thumbnail

Amazon Consumer CEO Jeff Wilke to leave next year, will be replaced by operations chief Dave Clark

GeekWire

He oversees businesses that generated more than $200 billion in net sales in 2019, representing nearly 90% of Amazon’s overall net sales last year. He grew up in Pittsburgh, studied chemical engineering at Princeton University, and did his graduate work in MIT’s Leaders for Global Operations program.

Chemicals 135
article thumbnail

The major blind spot in Bill Gates’s pandemic prevention plan

Vox

Pharmaceutical companies raked in record profits from Covid-19 drugs and vaccines; tech stocks boomed , and the number of billionaires around the world shot up by 30 percent. Private drug companies did develop effective vaccines that helped save millions of lives — but so did Cuba’s nationalized pharmaceutical industry.